The liver maintains the physiologic and metabolic balance of the body. Therefore, disease of the liver may have numerous effects throughout the body: it may cause disturbances in carbohydrate, lipid, amino acid, and vitamin metabolism and interfere with protein synthesis, blood clotting, and detoxification of endogenous and exogenous substances (Table 5-1). TABLE 5-1 CLINICAL FEATURES OF LIVER FAILURE Noninfectious causes of liver inflammation include toxic and immunologic disorders of the liver (see Table 5-2). These are discussed together because certain forms of toxic hepatitis may mimic autoimmune disorders or may be mediated through hypersensitivity reactions. A large variety of substances can cause liver damage, and they are associated with an equally large variety of lesions. A selection is shown in Table 5-3. TABLE 5-2 CHARACTERISTICS OF PRIMARY AUTOIMMUNE DISORDERS OF THE LIVER* Overlap syndromes combine features of cholestatic and chronic hepatitic forms of diseases, e.g., AIH + PBC, PBC + PSC, or PBC + sarcoidosis. *AIH indicates autoimmune hepatitis; PBC, primary biliary cirrhosis; PSC, primary sclerosing cholangitis. TABLE 5-3 TOXIC HEPATITIS AND ITS LESIONS There are 3 major groups of autoimmune disorders affecting the liver: primary hepatic autoimmune diseases (Table 5-3), liver diseases with secondary autoimmune component, and systemic autoimmune diseases involving the liver. Cystic fibrosis (CF) is the most common autosomal recessively inherited disease in children and young adults, with an incidence in Western populations of 1 in 2000 live births. It is caused by variable mutations of the CF gene on chromosome 7 (7q31-32). The primary defect caused by these mutations is in chloride ion channels, which transport chloride ions across epithelial barriers. Deficient chloride ion transport interferes with sodium and water secretion in exocrine glands, resulting in the production of a viscous mucoid material that obstructs glandular ducts in salivary glands, bronchial glands, the pancreas, and others. (See also Fig. 3-3.) TABLE 5-4 MEMBERS AND CHARACTERISTICS OF THE HEPATITIS VIRUSES* TABLE 5-5 GROSS FEATURES AS RELATED TO THE PATHOGENESIS OF LIVER CIRRHOSIS*
Liver, Gallbladder, and Pancreas
Clinical Feature
Pathogenesis
Jaundice
a. Intracellular retention of bilirubin (hepatocyte failure)
b. Intercellular and canalicular (bile stasis)
Malabsorption, weight loss, bleeding tendency, muscle wasting
Bile, enzyme, and vitamin deficiency
Edema, muscle wasting
Decreased protein (albumin) synthesis
Spider nevi, palmar erythema, gynecomastia
Disturbed hormone metabolism
Ascites, splenomegaly, varices (gastroesophageal)
Portal hypertension
Hepatic encephalopathy
Toxic metabolites (acetoin, acyloin, ammonia)
Hepatorenal syndrome
Cause unknown (renal vasoconstriction?)
Inflammatory Diseases of the Liver
Features
AIH
PBC
PSC
Serology (autoantibodies)
Antinuclear (ANA)
Anti–smooth muscle (ASMA)
Anti–liver/kidney membrane (LKM)
Antiliver (LSP)
Anti–native DNA
Antiribosomal
Antimitochondrial (AMA)
ASMA
Anti–bile proteins
Antithyroid
LSP
ANA
Antineutrophils (ANCA)
Anti–bile duct epithelia
Genetics
Nonspecific
Female predominance
Male predominance
Increased expression: HLA-DR3, HLA-DRW52a, HLA-B8 (DR2,4, DRb12)
Associated diseases
Rheumatoid arthritis
Pernicious anemia
Cryoglobulinemia
Peripheral neuropathy
Hemolytic anemia
Raynaud syndrome
Thyroid dysfunction
Seronegative arthritis
Scleroderma
Keratoconjunctivitis
Ulcerative colitis
Riedel thyroiditis
Retroperitoneal fibrosis
Orbital pseudotumor (may be complicated by cholangiocarcinoma)
Mechanism
Lesion
Exemplary Substances
Direct and indirect toxicity
Hepatocellular necrosis and steatosis
Alcohol, CCl4, phosphorus methyl-DOPA, tetracyclines
Cholestatic
Hepatocanalicular cholestasis
Steroids
Hypersensitivity
Hepatocellular and hepatocanalicular, necrosis, cholestasis, granulomatous
Erythromycin, chlorpromazine phenytoin
Vasculitis (panarteritis nodosa type)
Penicillin, allopurinol, sulfathiazole chlorpromazide, diphenylhydantoin, chlorothiazide, methamphetamine
Sclerosing cholangitis type
Floxuridine
Metabolic
Hepatocellular and hepatocanalicular
Isoniazid, halothane
Cystic Fibrosis (Mucoviscidosis)
Neoplasms of the Pancreas
Name (Molecule)
Family
Transmission
Incubation, weeks
Disease
Carrier
Chronic
Cancer
HAV (ssRNA)
Picorna
Enteral
2–6
Hepatitis, fulminant hepatitis
0
0
0
HBV (dsDNA)
Hepadna
Parenteral
4–26
Hepatitis, fulminant hepatitis, cirrhosis
−1%
−10%
Yes
HCV (ssRNA)
Flavivirus
Parenteral
2–26
Hepatitis, cirrhosis, extrahepatic disorders
−1%
−50%
Yes
HDV (ssRNA)
Subviral satellite (HBV helper)
Parenteral
4–7 (super- infection)
Hepatitis, fulminant hepatitis
−10%
−5%
0
HEV (ssRNA)
Calicivirus
Enteral
2–8
Hepatitis
?
0
0
HGV (ssRNA)
Flavivirus
Parenteral
?
Hepatitis, extrahepatic disorders in drug addicts
−2%
0
?
Gross Appearance
Pathogenesis
Diffuse, finely nodular (classic Laennec type: with atrophy)
Post–hepatitis virus cirrhosis
Same with or without fatty infiltration
Post–alcoholic cirrhosis
Diffuse, medium-sized nodular, dark purple (classic Hanot type with hypertrophy)
Chronic congestive (practically only seen in constrictive pericarditis)
Same with severe jaundice (green liver)
Primary biliary cirrhosis or chronic sclerosing cholangitis
Same with “dirty” gray-brown appearance (and similarly pigmented pancreas)
Hemochromatosis, Wilson disease
Diffuse, irregularly nodular, preferentially small- to medium-sized nodular
Autoimmune hepatitis and cirrhosis
Irregular, medium- to large-sized nodular, with jaundice (green liver)
Secondary biliary cirrhosis (i.e., extrahepatic bile duct obstruction)
Same with regular color or with fatty infiltration
“Postnecrotic” cirrhosis of variable etiology (e.g., post-HSV + alcoholic or other toxic influences)
Stay updated, free articles. Join our Telegram channel
Full access? Get Clinical Tree